$CRIS News Insiders are bullish on these stocks 11:14

New Post Public Reply Private Reply Replies (0) Message Board

Jul 26, 2014 at 11:11 AM

$CRIS News

Insiders are bullish on these stocks 11:14 a.m. Dec. 11, 2012 - Insider Monkey
FDA approves Roche-Curis drug to treat skin cancer 2:10 p.m. Jan. 30, 2012 - MarketWatch.com
Drug stocks climb; Siga sinks on contract woes 3:53 p.m. June 14, 2011 - Val Brickates Kennedy
Analyst downgrades weigh on drug stocks 3:47 p.m. April 29, 2011 - Val Brickates Kennedy
Analyst downgrades weigh on drug stocks 10:01 a.m. April 29, 2011 - Val Brickates Kennedy
Wednesday’s biggest advancers and decliners 4:35 p.m. April 6, 2011 - Kate Gibson
Optimer, Curis, Orchid in drug-sector spotlight 4:33 p.m. April 6, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 3:34 p.m. March 21, 2011 - Kate Gibson
Curis leads advance for drug stocks 2:38 p.m. March 21, 2011 - Val Brickates Kennedy
Curis soars on skin cancer trial 9:02 a.m. March 21, 2011 - Val Brickates Kennedy
The best biotech stocks to own now 1:01 a.m. Jan. 13, 2011 - Michael Shulman
Monday's biggest gaining and declining stocks 6:16 p.m. Aug. 9, 2010 - MarketWatch
Wednesday's biggest gaining and declining stocks 4:54 p.m. June 16, 2010 - MarketWatch
Friday's biggest gaining and declining stocks 3:53 p.m. Jan. 22, 2010 - MarketWatch
Drug stocks mixed; Curis and Achillion tumble 12:17 p.m. Jan. 22, 2010 - Val Brickates Kennedy
BEFORE THE BELL -2: US HOT STOCKS TO WATCH 8:54 a.m. Sept. 3, 2009 - Dow Jones
Schering-Plough, Merck slide on Vytorin woes 1:46 p.m. Dec. 12, 2007 - Val Brickates Kennedy
Drugs stocks post modest losses 10:03 a.m. Sept. 25, 2007 - William Spain
Drug, biotech stocks trade broadly lower; Dendreon plunges 2:22 p.m. May 9, 2007 - Carolyn Pritchard
Drug stocks mixed, Dynavax rockets on allergy study 4:40 p.m. Oct. 5, 2006 - Val Brickates Kennedy

Exelixis (EXEL) Jumps: Stock Adds 11.4% in Session - Tale of the Tape 9:39 a.m. July 25, 2014 - Zacks.com
Celsion (CLSN) in Focus: Stock Adds 5.3% in Session - Tale of the Tape 8:51 a.m. July 25, 2014 - Zacks.com
Illumina (ILMN) Tops Q2 Earnings & Revenues, Ups Guidance - Analyst Blog 12:00 p.m. July 24, 2014 - Zacks.com
Amicus Therapeutics (FOLD) Jumps: Stock Rises 7.1% - Tale of the Tape 9:39 a.m. July 24, 2014 - Zacks.com
Array BioPharma, Inc. (ARRY) Jumps: Stock Surges 10.7% Higher - Tale of the Tape 9:11 a.m. July 24, 2014 - Zacks.com
Biogen Idec (BIIB) Soars: Stock Adds 11.2% in Session - Tale of the Tape 8:51 a.m. July 24, 2014 - Zacks.com
Ultragenyx (RARE) Jumps: Stock Moves 7.8% Higher - Tale of the Tape 9:25 a.m. July 21, 2014 - Zacks.com
CVS Caremark Forms Clinical Alliances to Boost Health Care - Analyst Blog 3:20 p.m. July 17, 2014 - Zacks.com
Ligand Pharmaceuticals (LGND) in Focus: Stock Falls 6.7% - Tale of the Tape 8:31 a.m. July 17, 2014 - Zacks.com
CVS Caremark to Expand with Navarro Discount Pharmacy Buyout - Analyst Blog 3:10 p.m. July 15, 2014 - Zacks.com
Bruker's Inspire Mapping System Fails to Inspire Share Prices - Analyst Blog 3:20 p.m. July 14, 2014 - Zacks.com
Sarepta Therapeutics Slumps: SRPT Tanks 12.9% in Session - Tale of the Tape 8:42 a.m. July 11, 2014 - Zacks.com
Should You Get Rid of Kamada (KMDA) Now? - Tale of the Tape 8:34 a.m. July 11, 2014 - Zacks.com
Will Curis (CRIS) Crush Estimates at Its Next Earnings Report? - Tale of the Tape 8:43 a.m. July 10, 2014 - Zacks.com
China Biologic Products, Inc. (CBPO) Jumps: Stock Surges 10.8% - Tale of the Tape 9:11 a.m. July 9, 2014 - Zacks.com
Ultragenyx Pharmaceutical Slumps: RARE Plunges 11.7% in Session - Tale of the Tape 8:33 a.m. July 9, 2014 - Zacks.com
Curis (CRIS) Soars: Stock Adds 11.4% in Session - Tale of the Tape 8:51 a.m. July 1, 2014 - Zacks.com
Basket Of Biotech Bargains To Buy And Hold 4:23 p.m. June 30, 2014 - Seeking Alpha
Curis and Roche File Label Expansion for Erivedge - Analyst Blog 5:44 p.m. June 25, 2014 - Zacks.com
$2 Or Less: 2 Speculative Biotechs Moving Up 4:52 p.m. June 23, 2014 - Seeking Alpha

Health Care Sector Stocks Technical Review: Valeant Pharma, Teva Pharma Industries, Novo Nordisk, Curis, and Amarin 8:10 a.m. July 17, 2014 - PR Newswire - PRF
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health 6:20 a.m. July 2, 2014 - PR Newswire - PRF
Curis Announces Investigational New Drug Application Filing by Roche to Initiate a Phase 2 Study of Erivedge(R) (vismodegib) in Idiopathic Pulmonary Fibrosis 7:01 a.m. June 23, 2014 - GlobeNewswire
Curis to Present at the JMP Securities Healthcare Conference 7:01 a.m. June 18, 2014 - GlobeNewswire
Technical Snapshot on Biotech Stocks -- Research on Aegerion Pharma, Biogen Idec, Lexicon Pharma, and Curis 8:30 a.m. June 5, 2014 - PR Newswire - PRF
Curis Announces Executive Management Transition 7:00 a.m. June 3, 2014 - GlobeNewswire
Curis to Present at the Jefferies 2014 Global Healthcare Conference 7:01 a.m. May 29, 2014 - GlobeNewswire
Curis Announces Abstracts for Its Partnered Programs, Erivedge(R) and Debio 0932 to be Presented at the 2014 ASCO Annual Meeting 7:01 a.m. May 23, 2014 - GlobeNewswire
Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2014 11:35 a.m. May 21, 2014 - PR Newswire - PRF
Curis Reports First Quarter 2014 Financial Results 7:02 a.m. May 8, 2014 - GlobeNewswire
Curis to Release First Quarter 2014 Financial Results and Hold Conference Call on May 8, 2014 7:02 a.m. May 1, 2014 - GlobeNewswire
Curis Announces U.S. Patent Issuance Covering CUDC-907 Composition-of-Matter 7:02 a.m. April 30, 2014 - GlobeNewswire
Curis to Present at the Deutsche Bank 39th Annual Health Care Conference 6:46 a.m. April 30, 2014 - GlobeNewswire
Curis and Debiopharm Group Report Preclinical Data for Debio 0932 at AACR Annual Meeting 2014 3:30 a.m. April 8, 2014 - PR Newswire - PRF
Curis Reports CUDC-907 and CUDC-427 Data at AACR Annual Meeting 2014 4:06 p.m. April 7, 2014 - GlobeNewswire
Curis and Debiopharm Group(TM) Report Preclinical Data for Debio 0932 at AACR Annual Meeting 2014 4:03 p.m. April 7, 2014 - GlobeNewswire
Curis to Present at the 13th Annual Needham Healthcare Conference 7:20 a.m. April 2, 2014 - GlobeNewswire
Curis Announces Removal of FDA Partial Clinical Hold on CUDC-427 7:01 a.m. March 31, 2014 - GlobeNewswire
Curis Announces Presentation of Data for CUDC-907, CUDC-427 and Debio 0932 at AACR Annual Meeting 6:30 a.m. March 31, 2014 - GlobeNewswire
Curis to Present at the 26th Annual ROTH Conference 8:11 a.m. March 4, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Medline's MedTrans Rodeo: Honoring Driver Excellence

Rollin' Down the Road of Excellence In the world of healthcare logistics, Medline's MedTrans team isn't just steering trucks—they're steering safety culture and supply chain efficiency. This October, they wrapped up their fourth annual National Truck Rodeo in Mundelein, Illinois. And let me tell you, it was more than just a fancy event. It was about celebrating the real...

Quest Diagnostics Faces Class Action After Data Breach

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...

Think Together Marks 20 Years of ASES Impact in CA

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

TORRAS Stands Tall with iPhone 18 Pro Cases

By Riley Hayes Updated Oct 24, 2026 Category News Views 150

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Galien Recognizes Kerry for Transformative Global Health Work

Kerry's Legacy: A Symbol of Global Unity In the ever-thickening jungle of geopolitics and global health, it's rare to find a beacon as steadfast as John Kerry. This year, The Galien Foundation saw fit to honor him with the 2026 Roy Vagelos Pro Bono Humanum Award for Global Health Equity. This ain't just some shiny trinket—it’s a testament to his lifetime of ripping...

PZZA Faces Class Action: Strategic Shake-up or Misstep?

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Monterey Desalination Project: Costs, Challenges & Future

Water Woes Dragging on in Monterey? Alright, let's dive into the nitty-gritty of this water supply saga in the Monterey Peninsula. If you're wondering why California American Water is hustling so hard, it's because the taps around here ain't running like they should. This mess has been stretching on for ages, with everyone thirsty for a sustainable answer. The Cost of...